These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 36610832

  • 1. Use of hospital resources in ICU inpatients with infections caused by carbapenem-resistant Gram-negative bacteria: A real clinical practice-based study in Spain.
    Ferrer R, Garnacho-Montero J, Rascado P, Contreras S, Cantón-Bulnes L, Barral P, Del Cerro I, Badia X.
    Enferm Infecc Microbiol Clin (Engl Ed); 2023 Mar; 41(3):162-168. PubMed ID: 36610832
    [Abstract] [Full Text] [Related]

  • 2. Determining the burden of infectious diseases caused by carbapenem-resistant gram-negative bacteria in Spain.
    Cantón R, Huarte R, Morata L, Trillo-Mata JL, Muñoz R, González J, Tort M, Badia X.
    Enferm Infecc Microbiol Clin (Engl Ed); 2021 Apr; 39(4):179-183. PubMed ID: 32576392
    [Abstract] [Full Text] [Related]

  • 3. Clinical management of cUTI, cIAI, and HABP/VABP attributable to carbapenem-resistant Gram-negative infections in Spain.
    Ferrer R, Fariñas MC, Maseda E, Salavert M, Bou G, Díaz-Regañón J, López D, Lozano V, Gómez-Ulloa D, Fenoll R, Lara N, McCann E.
    Rev Esp Quimioter; 2021 Dec; 34(6):639-650. PubMed ID: 34806858
    [Abstract] [Full Text] [Related]

  • 4. Bloodstream infections in children caused by carbapenem-resistant versus carbapenem-susceptible gram-negative microorganisms: Risk factors and outcome.
    Ozsurekci Y, Aykac K, Cengiz AB, Basaranoglu ST, Sancak B, Karahan S, Kara A, Ceyhan M.
    Diagn Microbiol Infect Dis; 2017 Apr; 87(4):359-364. PubMed ID: 28089138
    [Abstract] [Full Text] [Related]

  • 5. The prospective evaluation of risk factors and clinical influence of carbapenem resistance in children with gram-negative bacteria infection.
    Sahbudak Bal Z, Bekmezci N, Soylu M, Sen S, Avcu G, Aydemir S, Vardar F.
    Am J Infect Control; 2018 Feb; 46(2):147-153. PubMed ID: 28982610
    [Abstract] [Full Text] [Related]

  • 6. Investigation and analysis of carbapenem-resistant gram-negative bacterial infection rates across hospitals in Shandong Province in China.
    Liu K, Xu H, Sun J, Liu Y, Li W.
    Front Public Health; 2022 Feb; 10():1014995. PubMed ID: 36420011
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of bloodstream infection pathogens in hemato-oncological patients and predictors of carbapenem-resistant gram-negative bacterial infections during febrile neutropenia.
    Schonardie AP, Beck E, Rigatto MH.
    Braz J Infect Dis; 2023 Feb; 27(2):102758. PubMed ID: 36809849
    [Abstract] [Full Text] [Related]

  • 8. Antibiotic consumption versus the prevalence of carbapenem-resistant Gram-negative bacteria at a tertiary hospital in China from 2011 to 2017.
    Zhang D, Hu S, Sun J, Zhang L, Dong H, Feng W, Lei J, Dong Y.
    J Infect Public Health; 2019 Feb; 12(2):195-199. PubMed ID: 30385238
    [Abstract] [Full Text] [Related]

  • 9. Complicated carbapenem-resistant infections: a treatment pathway analysis in Italian sites.
    Durante-Mangoni E, Bertolino L, Mastroianni C, Viale P, Bassetti M, Citton R, Gómez-Ulloa D, Roset M, McCann E.
    Infez Med; 2021 Feb; 29(3):434-449. PubMed ID: 35146349
    [Abstract] [Full Text] [Related]

  • 10. High excess costs of infections caused by carbapenem-resistant Gram-negative bacilli in an endemic region.
    Vargas-Alzate CA, Higuita-Gutiérrez LF, López-López L, Cienfuegos-Gallet AV, Jiménez Quiceno JN.
    Int J Antimicrob Agents; 2018 Apr; 51(4):601-607. PubMed ID: 29277527
    [Abstract] [Full Text] [Related]

  • 11. Trends and correlation between antibacterial consumption and carbapenem resistance in gram-negative bacteria in a tertiary hospital in China from 2012 to 2019.
    Liang C, Zhang X, Zhou L, Meng G, Zhong L, Peng P.
    BMC Infect Dis; 2021 May 17; 21(1):444. PubMed ID: 34001022
    [Abstract] [Full Text] [Related]

  • 12. Gastrointestinal Carriage of Vancomycin-Resistant Enterococci and Carbapenem-Resistant Gram-Negative Bacteria in an Endemic Setting: Prevalence, Risk Factors, and Outcomes.
    Vasilakopoulou A, Karakosta P, Vourli S, Tarpatzi A, Varda P, Kostoula M, Antoniadou A, Pournaras S.
    Front Public Health; 2020 May 17; 8():55. PubMed ID: 32257988
    [Abstract] [Full Text] [Related]

  • 13. Predicting acquisition of carbapenem-resistant Gram-negative pathogens in intensive care units.
    Dantas LF, Dalmas B, Andrade RM, Hamacher S, Bozza FA.
    J Hosp Infect; 2019 Oct 17; 103(2):121-127. PubMed ID: 31039381
    [Abstract] [Full Text] [Related]

  • 14. Impact of bloodstream infections caused by carbapenem-resistant Gram-negative pathogens on ICU costs, mortality and length of stay.
    Kousouli E, Zarkotou O, Polimeri K, Themeli-Digalaki K, Pournaras S.
    Infect Prev Pract; 2019 Jun 17; 1(2):100020. PubMed ID: 34368681
    [Abstract] [Full Text] [Related]

  • 15. Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: a case-case-control design in a prospective cohort study.
    Lima EM, Cid PA, Beck DS, Pinheiro LHZ, Tonhá JPS, Alves MZO, Lourenço ND, Santos RQ, Asensi MD, Marques JA, Bandeira CS, Rodrigues CAS, Gomes Junior SCS, Gomes MZR, Nucleus of Hospital Research study collaborators.
    Antimicrob Resist Infect Control; 2020 Aug 14; 9(1):132. PubMed ID: 32795380
    [Abstract] [Full Text] [Related]

  • 16. Cost of hospitalised patients due to complicated urinary tract infections: a retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: the COMBACTE-MAGNET, RESCUING study.
    Vallejo-Torres L, Pujol M, Shaw E, Wiegand I, Vigo JM, Stoddart M, Grier S, Gibbs J, Vank C, Cuperus N, van den Heuvel L, Eliakim-Raz N, Carratala J, Vuong C, MacGowan A, Babich T, Leibovici L, Addy I, Morris S, RESCUING Study Group and Study Sites.
    BMJ Open; 2018 Apr 12; 8(4):e020251. PubMed ID: 29654026
    [Abstract] [Full Text] [Related]

  • 17. Incidence and outcomes of multidrug-resistant gram-negative bacteria infections in intensive care unit from Nepal- a prospective cohort study.
    Siwakoti S, Subedi A, Sharma A, Baral R, Bhattarai NR, Khanal B.
    Antimicrob Resist Infect Control; 2018 Apr 12; 7():114. PubMed ID: 30275945
    [Abstract] [Full Text] [Related]

  • 18. [Surveillance of resistance in the intensive care units using a cumulative antibiogram].
    Yürüyen C, Daldaban Dinçer Ş, Yanılmaz Ö, Boz ES, Aksaray S.
    Mikrobiyol Bul; 2018 Oct 12; 52(4):329-339. PubMed ID: 30522419
    [Abstract] [Full Text] [Related]

  • 19. Carbapenem-resistant gram-negative bacterial infection in intensive care unit patients: Antibiotic resistance analysis and predictive model development.
    Liao Q, Feng Z, Lin H, Zhou Y, Lin J, Zhuo H, Chen X.
    Front Cell Infect Microbiol; 2023 Oct 12; 13():1109418. PubMed ID: 36794004
    [Abstract] [Full Text] [Related]

  • 20. Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals.
    Papst L, Beović B, Pulcini C, Durante-Mangoni E, Rodríguez-Baño J, Kaye KS, Daikos GL, Raka L, Paul M, ESGAP, ESGBIS, ESGIE and the CRGNB treatment survey study group.
    Clin Microbiol Infect; 2018 Oct 12; 24(10):1070-1076. PubMed ID: 29410094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.